On Sept. 29, 2017, the FDA released its proposed rule to extend the compliance dates for Supplement and Nutrition Facts Labeling. The agency said it wanted to give manufacturers more time to comply, citing concerns from stakeholders that the current deadlines would not give them enough time to do so.
Both the US FDA and Health Canada are working towards reducing trans fats from the food supply by banning the use of partially hydrogenated oils (PHOs). For companies with a wide range of products, this could prove to be difficult. However, if you are already using Genesis R&D, things will be a little simpler.
We often receive questions regarding how ESHA implements recommendations for compliance from the FDA's Guidance for Industry documents into our software solutions. This blog briefly covers how we regard and use both types of guidance documents that the FDA publishes.